Vascular disrupting agents in clinical development.

Hinnen, P; Eskens, F A L M

Hinnen, P; Eskens, F A L M.

Affiliation

Hinnen P; Department of Medical Oncology, Erasmus University Medical Center, PO Box 2040, Rotterdam 3000 CA, The Netherlands.

Br J Cancer ; 96(8): 1159-65, 2007 Apr 23.

Article in En | MEDLINE | ID: mdl-17375046

Subject(s)

Antineoplastic Agents/therapeutic use; Blood Vessels/drug effects; Neoplasms/blood supply; Neoplasms/drug therapy; Neovascularization, Pathologic/drug therapy; Animals; Humans; Oligopeptides/therapeutic use; Organophosphorus Compounds/therapeutic use; Regional Blood Flow/drug effects; Stilbenes/therapeutic use; Tubulin Modulators/therapeutic use; Xanthones/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Vessels / Neoplasms / Neovascularization, Pathologic / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2007 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google